Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Xtant Medical Holdings (XTNT) Non Operating Income (2016 - 2025)

Xtant Medical Holdings (XTNT) has disclosed Non Operating Income for 16 consecutive years, with -$2.8 million as the latest value for Q3 2025.

  • On a quarterly basis, Non Operating Income rose 3.75% to -$2.8 million in Q3 2025 year-over-year; TTM through Sep 2025 was -$4.1 million, a 68.29% increase, with the full-year FY2024 number at -$4.2 million, down 8446.94% from a year prior.
  • Non Operating Income was -$2.8 million for Q3 2025 at Xtant Medical Holdings, down from $1.0 million in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $10.3 million in Q3 2023 to a low of -$9.1 million in Q4 2023.
  • A 5-year average of -$557421.1 and a median of -$464000.0 in 2022 define the central range for Non Operating Income.
  • Peak YoY movement for Non Operating Income: tumbled 35800.0% in 2022, then soared 2444.55% in 2023.
  • Xtant Medical Holdings' Non Operating Income stood at -$466000.0 in 2021, then increased by 0.43% to -$464000.0 in 2022, then plummeted by 1859.05% to -$9.1 million in 2023, then skyrocketed by 86.12% to -$1.3 million in 2024, then crashed by 123.69% to -$2.8 million in 2025.
  • Per Business Quant, the three most recent readings for XTNT's Non Operating Income are -$2.8 million (Q3 2025), $1.0 million (Q2 2025), and -$1.0 million (Q1 2025).